ID   Y9-iPSC
AC   CVCL_DD56
SY   Y09-iPSC
DR   Wikidata; Q54995196
RX   PubMed=25843045;
RX   PubMed=27191603;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=27191603
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 11
ST   D21S11: 28
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DD55 ! ND34791
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
RX   PubMed=25843045; DOI=10.1016/j.stemcr.2015.02.019; PMCID=PMC4437475;
RA   Shaltouki A., Sivapatham R., Pei Y., Gerencser A.A., Momcilovic O.,
RA   Rao M.S., Zeng X.-M.;
RT   "Mitochondrial alterations by PARKIN in dopaminergic neurons using
RT   PARK2 patient-specific and PARK2 knockout isogenic iPSC lines.";
RL   Stem Cell Reports 4:847-859(2015).
//
RX   PubMed=27191603; DOI=10.1371/journal.pone.0154890; PMCID=PMC4871453;
RA   Momcilovic O., Sivapatham R., Oron T.R., Meyer M., Mooney S.,
RA   Rao M.S., Zeng X.-M.;
RT   "Derivation, characterization, and neural differentiation of
RT   integration-free induced pluripotent stem cell lines from Parkinson's
RT   disease patients carrying SNCA, LRRK2, PARK2, and GBA mutations.";
RL   PLoS ONE 11:E0154890-E0154890(2016).
//